跳至主要内容
临床试验/NCT00225407
NCT00225407Unknown1 期

A Double-Blind, Randomised, Placebo-Controlled, Cross-Over Study on the Pharmacokinetics and Effects of Cannabis

UMC Utrecht1 个研究点 分布在 1 个国家目标入组 27 人开始时间: 2005年7月1日最近更新:
适应症
相关药物

试验速览

阶段
1 期
发起方
UMC Utrecht
入组人数
27
试验地点
1
主要终点
Serum concentration over time

研究概览

简要总结

The purpose of this study is to investigate the processing of cannabis, and to investigate the occurrence of effects of cannabis on the cardiovascular system and the central nervous system; at higher levels of exposure.

详细描述

In Europe, cannabis is the most illicit used drug, mainly for its psychoactive properties (becoming "high" or "stoned"). The active compound in cannabis is THC (tetrahydrocannabinol). In recent years the strength of cannabis (marihuana) available on the market in the Netherland has increased (especially "netherweed"). The THC-content has increased from on average 8.6% in 2000 to on average 20.3% in 2004. Experienced users adapt their habit of smoking to the strength of the cannabis sigaret (joint). However, there is also a group of people, mainly young ones, who intent to smoke the joint entirely, and can therefore be exposed to higher levels of THC. Information is lacking about the effects of cannabis at higher levels of exposure. Because of this, the Ministry of Health, Welfare, and Sports of the Netherlands ordered the investigators to perform a study to gain more insight in this issue.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Prevention
盲法
Double

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • Cannabis users (2-9 joints per month)

排除标准

  • Psychiatric illness
  • Evidence of excessive alcohol abuse
  • Use of other drugs

结局指标

主要结局

Serum concentration over time

Physical parameters (heart rate, blood pressure)

Psychomotor tests (such continuous attention)

Event related potentials

次要结局

  • Self-reporting questionnaires

研究者

发起方
UMC Utrecht
申办方类型
Other

研究点 (1)

Loading locations...

相似试验